Table 2.
Clinical sample | Country | Reference | ||||
---|---|---|---|---|---|---|
No, isolates | C. albicans, n (%) | NAC n (%) | Dominate species | |||
194* | 104(49.8%) | 90 (43.1%) | Various | Ethiopia | C. albicans, C. krusei, C. fabata | * |
177 | 139(78.5) | 38(21.5) | Oral (HIV patients | Ethiopia | C. albicans, C. glabrata,C. tropicalis | Mulu et al, 2013 [16] |
81 | 51(58.6) | 30(41.4) | Vaginal swab | Ethiopia | C. albicans, C. krusei,C. dubliniesis | Bitew and Abebaw, 2018 [17] |
63 | 38(60.3) | 25(39.7) | Vaginal swab | Egypt | C. albicans, C. glabrata, C. krusei | ElFeky et al, 2016 [18] |
111 | 44(39.6) | 67(60.4) | Various | India | C. albicans, C. krusei, C tropicalis | Mohandas & Balla 2011 [19] |
90 | 33(36.7) | 57(63.3) | Various | India | C. albicans, C. tropicalis,C. parapsilosis | Das et al 2016 [20] |
102 | 37(36.3) | 65(63.7) | Various | India | C. tropicalis, C. albicans.C. guilliermondii | Sida et al, 2017 [21] |
250 | 154(61.6) | 96(38.4) | Oral cavity | Thailand | C. albicans, C. glabrata, C. tropicalis | Muadcheingka&Tantivitayakul,2015 [22] |
108 | 61(56.5) | 47(43.5) | Blood | Taiwan | C. albicans, C. glabrata, C. tropicalis | Chi et al,2011 [23] |
90 | 33(36.7) | 57(63.3) | Various | India | C. tropicalis, C.albicans. C. glabrata | Kaur et al, 2016 [24] |
103 | 80(77.8) | 23(22.3) | Oral (HIV patients) | Brazil | C.albicans, C. tropicalis, C. parapsilosis | Ribeiro, et al, 2015 [25] |
1062 | 573(54) | 489 (46) | Various | Germany &Austria | C. albicans, C. glabrata, C. parapsilosis | Schmalreck et al, 2012 [26] |
580 | 420(72.4) | 160(27.6) | Vaginal swab | America | C. albicans, C. glabrata, C. parapsilosis | Richter et al, 2005 [27] |
428 | 273(63.8) | 155(36.2) | Various | Iran | C. albicans. C. tropicalis, C. parapsilosis | Badiee et al, 2011 [28] |
103 | 43(42) | 60(58) | Blood | Latin America | C. albicans. C. tropicalis, C. parapsilosis | Godoy et al, 2003 [29] |
* = current study